6.29
-0.04(-0.63%)
Currency In USD
| Previous Close | 6.33 |
| Open | 6.35 |
| Day High | 6.67 |
| Day Low | 6.15 |
| 52-Week High | 19.49 |
| 52-Week Low | 4.16 |
| Volume | 125,947 |
| Average Volume | 55,313 |
| Market Cap | 50.29M |
| PE | -3.68 |
| EPS | -1.71 |
| Moving Average 50 Days | 5.03 |
| Moving Average 200 Days | 5.52 |
| Change | -0.04 |
If you invested $1000 in electroCore, Inc. (ECOR) since IPO date, it would be worth $21.13 as of January 14, 2026 at a share price of $6.29. Whereas If you bought $1000 worth of electroCore, Inc. (ECOR) shares 5 years ago, it would be worth $243.8 as of January 14, 2026 at a share price of $6.29.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
TAC-STIM Demonstrates Significant Performance Improvements in Active-Duty United States Air Force Airmen
GlobeNewswire Inc.
Dec 02, 2025 1:00 PM GMT
ROCKAWAY, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a bioelectronic technology company, today announced the publication of a peer reviewed paper titled “Non-Invasive Transcutaneous Va
electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
GlobeNewswire Inc.
Nov 10, 2025 9:05 PM GMT
ROCKAWAY, N.J., Nov. 10, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the Canaccord Genuity MedTech, Diagnostics and D
electroCore to Announce Third Quarter September 30, 2025 Financial Results on Wednesday, November 5, 2025
GlobeNewswire Inc.
Oct 23, 2025 12:11 PM GMT
ROCKAWAY, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the third quarter ended September 30, 2025